Outpatient Treatment of Infective Endocarditis (IE) at Physician Office Infusion Centers (POICs): A 2-Year Analysis of Clinical and Economic Outcomes
Authors:
Brian S. Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX
Richard M. Mandel, MD, FIDSA – Southern Arizona Infectious Disease Specialists, PLC, Tucson, AZ
Jorge R. Bernett, MD – Infectious Disease Doctors Medical Group, Walnut Creek, CA
Barry Statner, MD, FRCPC, FIDSA -Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
John S. Adams, MD, FIDSA, FSHEA – Knoxville Infectious Disease Consultants, P.C., Knoxville, TN
Alfred E. Bacon III, MD – Infectious Disease Associates, PA, Newark, DE
Kimberly Couch, PharmD, MA, FIDSA, FASHP – Healix Infusion Therapy, Inc., Sugar Land, TX
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Inc., Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX